1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Joint Pain Injections Market
2.2. Global Joint Pain Injections Market, By Injection, 2024 (US$ Million)
2.3. Global Joint Pain Injections Market, By Joint, 2024 (US$ Million)
2.4. Global Joint Pain Injections Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Joint Pain Injections Market: Competitive Analysis
3.1. Market Positioning of Key Joint Pain Injections Market Vendors
3.2. Strategies Adopted by Joint Pain Injections Market Vendors
3.3. Key Industry Strategies

4. Joint Pain Injections Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Joint Pain Injections Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Hyaluronic Acid Injections
5.3.2. Corticosteroid Injections
5.3.3. Others

6. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Hip Joint
6.3.2. Knee & Ankle
6.3.3. Shoulder & Elbow
6.3.4. Facet Joints of the Spine
6.3.5. Others


7. North America Joint Pain Injections Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
7.3. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
7.4.Joint Pain Injections Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
7.4.1.1.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
7.4.1.2.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
7.4.1.3.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)

8. UK and European Union Joint Pain Injections Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.3. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.Joint Pain Injections Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.1.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.2.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.3.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.4.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.5.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
8.4.1.6.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)

9. Asia Pacific Joint Pain Injections Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.3. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.Joint Pain Injections Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.1.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.2.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.3.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.4.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.5.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
9.4.1.6.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)

10. Latin America Joint Pain Injections Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
10.3. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
10.4.Joint Pain Injections Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
10.4.1.1.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
10.4.1.2.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
10.4.1.3.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)

11. Middle East and Africa Joint Pain Injections Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
11.3. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
11.4.Joint Pain Injections Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
11.4.1.1.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
11.4.1.2.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Joint Pain Injections Market: By Injection, 2023-2033, USD (Million)
11.4.1.3.2. Joint Pain Injections Market: By Joint, 2023-2033, USD (Million)

12. Company Profile
12.1. Allergan, Plc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Anika Therapeutics, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bioventus LLC
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Chugai Pharmaceutical Co., Ltd.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Flexion Therapeutics, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Ferring B.V.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Pfizer, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Sanofi S.A.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. SEIKAGAKU Corporation
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Zimmer Biomet Holdings, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives